Llwytho...
Agonist‐induced desensitisation of β(3)‐adrenoceptors: Where, when, and how?
β(3)‐Adrenoceptor agonists have proven useful in the treatment of overactive bladder syndrome, but it is not known whether their efficacy during chronic administration may be limited by receptor‐induced desensitisation. Whereas the β(2)‐adrenoceptor has phosphorylation sites that are important for d...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Br J Pharmacol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6592865/ https://ncbi.nlm.nih.gov/pubmed/30809805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14633 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|